Skip to main content

Decellularized Extracellular Matrix (ECM)

Decellularized extracellular matrices are tissue scaffolds produced by removing all cellular and antigenic components from xenogenic (usually porcine) tissue, leaving the native collagen, elastin, laminin, and glycosaminoglycan architecture intact.[1][2]

Concept

The decellularized matrix serves as a 3D scaffold that:

  • Supports host cell infiltration
  • Directs tissue remodeling into the matching native tissue
  • Avoids the immune response of cellular xenogeneic grafts
  • Provides structural cues (composition, mechanics, topography) that matched the source tissue

Common Source Tissues

  • Porcine small intestinal submucosa (SIS) — historically most studied for urologic applications; see Porcine SIS
  • Porcine urinary bladder matrix (UBM) — tissue-matched to bladder reconstruction
  • Porcine dermal matrix
  • Human decellularized allograft tissue

Urologic Applications (Investigational)

  • Urethral substitution — patch or tubularized grafts for long-segment urethral stricture
  • Bladder augmentation — partial bladder replacement
  • Ureteral reconstruction — replacement conduits
  • Vaginal reconstruction — neovaginal creation

Current Status

Despite two decades of investigation, decellularized ECM constructs have not reached routine clinical practice for urinary-tract substitution. Barriers include:[1][2][3]

  • Inconsistent remodeling — graft fibrosis or failure to re-epithelialize
  • Contracture of the neo-organ
  • Mechanical failure at anastomoses
  • Difficulty seeding with autologous cells reliably

The Bowel Paradox

Despite the field's sustained effort, autologous bowel remains the gold standard for bladder substitution and urinary diversion — its complications notwithstanding. Tissue-engineered constructs have not matched bowel's durability, scalability, and clinical track record.

References

1. Davis NF, Cunnane EM, Quinlan MR, et al. Biomaterials and Regenerative Medicine in Urology. Advances in Experimental Medicine and Biology. 2018;1107:189–198. doi:10.1007/5584_2017_139

2. Duan L, Wang Z, Fan S, Wang C, Zhang Y. Research Progress of Biomaterials and Innovative Technologies in Urinary Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 2023;11:1258666. doi:10.3389/fbioe.2023.1258666

3. Sharma S, Basu B. Biomaterials Assisted Reconstructive Urology: The Pursuit of an Implantable Bioengineered Neo-Urinary Bladder. Biomaterials. 2022;281:121331. doi:10.1016/j.biomaterials.2021.121331

See also: Synthetic Polymer Scaffolds, Composite Scaffolds, Bowel Segments.